308 related articles for article (PubMed ID: 25787955)
21. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
Paladini CA; Celada P; Tepper JM
Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
[TBL] [Abstract][Full Text] [Related]
22. Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice.
Shanahan NA; Holick Pierz KA; Masten VL; Waeber C; Ansorge M; Gingrich JA; Geyer MA; Hen R; Dulawa SC
Biol Psychiatry; 2009 Mar; 65(5):401-8. PubMed ID: 19013555
[TBL] [Abstract][Full Text] [Related]
23. Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus.
Asaoka N; Nagayasu K; Nishitani N; Yamashiro M; Shirakawa H; Nakagawa T; Kaneko S
Neuropharmacology; 2015 Aug; 95():261-8. PubMed ID: 25863120
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the effect of cannabinoids on GABAergic neurotransmission in the substantia nigra pars reticulata.
Wallmichrath I; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):326-34. PubMed ID: 11919658
[TBL] [Abstract][Full Text] [Related]
25. The Effect of Serotonin Receptor 5-HT1B on Lateral Inhibition between Spiny Projection Neurons in the Mouse Striatum.
Pommer S; Akamine Y; Schiffmann SN; de Kerchove d'Exaerde A; Wickens JR
J Neurosci; 2021 Sep; 41(37):7831-7847. PubMed ID: 34348999
[TBL] [Abstract][Full Text] [Related]
26. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
Mitchell SN; Greenslade RG; Cooper J
Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
[TBL] [Abstract][Full Text] [Related]
27. Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice.
de Groote L; Olivier B; Westenberg HG
Psychopharmacology (Berl); 2002 Aug; 162(4):419-24. PubMed ID: 12172696
[TBL] [Abstract][Full Text] [Related]
28. Nigral dopamine loss induces a global upregulation of presynaptic dopamine D1 receptor facilitation of the striatonigral GABAergic output.
Ding S; Li L; Zhou FM
J Neurophysiol; 2015 Mar; 113(6):1697-711. PubMed ID: 25552639
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis.
He M; Sibille E; Benjamin D; Toth M; Shippenberg T
Brain Res; 2001 May; 902(1):11-7. PubMed ID: 11376590
[TBL] [Abstract][Full Text] [Related]
30. 5-HT(1B) autoreceptor regulation of serotonin transporter activity in synaptosomes.
Hagan CE; McDevitt RA; Liu Y; Furay AR; Neumaier JF
Synapse; 2012 Dec; 66(12):1024-34. PubMed ID: 22961814
[TBL] [Abstract][Full Text] [Related]
31. Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease.
Barry J; Akopian G; Cepeda C; Levine MS
J Neurosci; 2018 May; 38(20):4678-4694. PubMed ID: 29691329
[TBL] [Abstract][Full Text] [Related]
32. Chronic fluoxetine treatment desensitizes serotoninergic inhibition of GABA inputs and the intrinsic excitability of dorsal raphe serotonin neurons.
Zhang W; Jin Y; Zhou FM
bioRxiv; 2024 May; ():. PubMed ID: 38766100
[TBL] [Abstract][Full Text] [Related]
33. 5-HT(1A) receptor sensitivity in 5-HT(1B) receptor KO mice is unaffected by chronic fluvoxamine treatment.
Vinkers CH; Groenink L; Pattij T; Olivier B; Bouwknecht JA
Eur J Pharmacol; 2011 Sep; 667(1-3):250-7. PubMed ID: 21723276
[TBL] [Abstract][Full Text] [Related]
34. 5-HT 1A/1B receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep: studies in 5-HT 1A and 5-HT 1B knockout mice.
Monaca C; Boutrel B; Hen R; Hamon M; Adrien J
Neuropsychopharmacology; 2003 May; 28(5):850-6. PubMed ID: 12637954
[TBL] [Abstract][Full Text] [Related]
35. Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine.
Stenfors C; Ross SB
Life Sci; 2002 Nov; 71(24):2867-2880. PubMed ID: 12377268
[TBL] [Abstract][Full Text] [Related]
36. D3 dopamine receptors interact with dopamine D1 but not D4 receptors in the GABAergic terminals of the SNr of the rat.
Cruz-Trujillo R; Avalos-Fuentes A; Rangel-Barajas C; Paz-Bermúdez F; Sierra A; Escartín-Perez E; Aceves J; Erlij D; Florán B
Neuropharmacology; 2013 Apr; 67():370-8. PubMed ID: 23238327
[TBL] [Abstract][Full Text] [Related]
37. The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice.
De Groote L; Olivier B; Westenberg HG
Eur J Pharmacol; 2002 Mar; 439(1-3):93-100. PubMed ID: 11937097
[TBL] [Abstract][Full Text] [Related]
38. Activation of postsynaptic 5-HT(1A) receptors by fluoxetine despite the loss of firing-dependent serotonergic input: electrophysiological and neurochemical studies.
Sprouse J; Braselton J; Reynolds L; Clarke T; Rollema H
Synapse; 2001 Jul; 41(1):49-57. PubMed ID: 11354013
[TBL] [Abstract][Full Text] [Related]
39. Fluoxetine potentiation of methylphenidate-induced neuropeptide expression in the striatum occurs selectively in direct pathway (striatonigral) neurons.
Van Waes V; Carr B; Beverley JA; Steiner H
J Neurochem; 2012 Sep; 122(5):1054-64. PubMed ID: 22738672
[TBL] [Abstract][Full Text] [Related]
40. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F
Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
